In this video, Dr. Vikramaditya Yadav of the University of British Columbia talks about using a unique biosynthesis platform to productively produce bioidentical, high purity, high grade cannabinoids. InMed collaborates with Dr. Yadav’s laboratory in developing a proprietary biosynthesis platform.
In the Media
UBC’s Dr. Yadav Talks about Producing Bio-identical Cannabinoids in the Lab using Biosynthesis
Share this post
Latest Media News
In this video, InMed Pharmaceuticals CEO Eric A. Adams speaks about the company’s ocular disease program. INM-088 is a cannabinol (CBN) formulation showing potential to
InMed’s therapeutic development of cannabinol and update on programs – Executive Interview with CEO Eric A. Adams
In this video, InMed Pharmaceuticals’ CEO Eric A. Adams speaks about the company’s therapeutic development of cannabinol (CBN), a rare cannabinoid showing potential to treat